Biomolecules 2014, 4(1), 315-353; doi:10.3390/biom4010315

Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation

* email, email and email
Received: 24 December 2013; in revised form: 11 February 2014 / Accepted: 27 February 2014 / Published: 14 March 2014
(This article belongs to the Special Issue Focus Update in Biomolecules)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The sphingolipids are one of the major lipid families in eukaryotes, incorporating a diverse array of structural variants that exert a powerful influence over cell fate and physiology. Increased expression of sphingosine kinase 1 (SPHK1), which catalyses the synthesis of the pro-survival, pro-angiogenic metabolite sphingosine 1-phosphate (S1P), is well established as a hallmark of multiple cancers. Metabolic alterations that reduce levels of the pro-apoptotic lipid ceramide, particularly its glucosylation by glucosylceramide synthase (GCS), have frequently been associated with cancer drug resistance. However, the simple notion that the balance between ceramide and S1P, often referred to as the sphingolipid rheostat, dictates cell survival contrasts with recent studies showing that highly potent and selective SPHK1 inhibitors do not affect cancer cell proliferation or survival, and studies demonstrating higher ceramide levels in some metastatic cancers. Recent reports have implicated other sphingolipid metabolic enzymes such as acid sphingomyelinase (ASM) more strongly in cancer pathogenesis, and highlight lysosomal sphingolipid metabolism as a possible weak point for therapeutic targeting in cancer. This review describes the evidence implicating different sphingolipid metabolic enzymes and their products in cancer pathogenesis, and suggests how newer systems-level approaches may improve our overall understanding of how oncogenic transformation reconfigures sphingolipid metabolism.
Keywords: sphingolipid; cancer; metabolism; sphingosine 1-phosphate; sphingosine kinase; ceramide; glucosylceramide; sphingomyelin; sphingomyelinase; glycolipid
PDF Full-text Download PDF Full-Text [863 KB, uploaded 14 March 2014 09:47 CET]

Export to BibTeX |

MDPI and ACS Style

Don, A.S.; Lim, X.Y.; Couttas, T.A. Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation. Biomolecules 2014, 4, 315-353.

AMA Style

Don AS, Lim XY, Couttas TA. Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation. Biomolecules. 2014; 4(1):315-353.

Chicago/Turabian Style

Don, Anthony S.; Lim, Xin Y.; Couttas, Timothy A. 2014. "Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation." Biomolecules 4, no. 1: 315-353.

Biomolecules EISSN 2218-273X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert